Strattera
Product Images NDC 68151-4486

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Strattera (NDC 68151-4486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (68151 4486)

Packaging label for Strattera 25 mg capsule showing the active ingredient atomoxetine HCl. The label includes manufacturer information (MFG: Lily), lot number C171575A, expiration date 07/14, product code W012614SN3, and a barcode with NDC 0000004486. It is marked RX only.*

FDA Label Image

Chemical Structure (Strattera1)

Chemical structure of the active ingredient in Strattera. The diagram shows a molecular structure with connected atoms including benzene rings, methyl groups, and a hydrochloride (HCl) component.*

FDA Label Image

Figure 1 (Strattera2)

Two line charts depicting mean weight percentile and mean height percentile over 36 months of treatment for Strattera. The left chart shows weight percentile trends for 203 subjects, while the right chart shows height percentile trends for 155 subjects, with both charts including error bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.